국제경영론-동아제약의 해외진출
- 최초 등록일
- 2013.11.15
- 최종 저작일
- 2013.05
- 21페이지/ 한컴오피스
- 가격 3,000원
목차
1. Purpose
2. Method
3. Selection of theory
4. Case description & analysis
5. Conclusion
본문내용
1.Purpose
1. Corporate Profile
(1) Dong-A Pharmaceutical
Nourishing tonic Bacchus D, specializing in the pharmaceutical companies that produce drugs Zydena 1932 founder 'Gang junghui Chairman shop' built after his name, Jongno-gu, Seoul junghakdong Gang junghui August 1949 by Dong-A Pharmaceutical Co., Ltd. was changed to start.
The major product, accounting for 15.34% of sales, as well as the Bacchus gastric mucosal protectant styrene, ischemic enhancer Opalmon, erectile dysfunction drug Zydena.
<중 략>
- medical insurance system
India's health insurance system is considerably insufficient. Look at the medical insurance system in India, approximately less than 5% of the total population in a public health insurance are subscribed that is less than 18% of urban workers. And private insurance subscribers is less than 2% of the total population.
India also in part of full health spending to be borne by individuals ratio is 71%. Improvements of this beneficiaries to increase insurance benefits and reduce the burden of health care spending for each individual to the development of the medical industry, Thus, the value of their investment in India will bring a synergistic effect.
참고 자료
없음